 | • レポートコード：QYR2104Z1262 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症用化学薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（レメジビル、アルディドール、ファビピビル、ロピナビル/リトナビル（LPV/r）、クロロキン、その他）、用途別市場規模（新型コロナウイルス感染症、インフルエンザ、マラリア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症用化学薬品の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症用化学薬品の種類別市場規模（レメジビル、アルディドール、ファビピビル、ロピナビル/リトナビル（LPV/r）、クロロキン、その他） ・新型コロナウイルス感染症用化学薬品の用途別市場規模（新型コロナウイルス感染症、インフルエンザ、マラリア、その他） ・新型コロナウイルス感染症用化学薬品の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症用化学薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症用化学薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症用化学薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症用化学薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gilead Sciences、AbbVie、Johnson & Johnson、Pfizer、Mylan、Bayer、Zhejiang Hisun、CSPC Pharmaceutical Group、Reyoung Pharmaceutical、Sihuan Pharmaceutical、Hikma Pharmaceuticals、Rising Pharmaceutical、Sun Pharma、Shanghai Pharma、Guangzhou Baiyunshan Guanghua Pharmaceutical、KPC Group、Jinghua Pharmaceutical Group、Zhongsheng Pharma、North China Pharmaceutical Group） ・結論 |
According to China’s clinical trials of COVID-19 treatment, the most clinically tested varieties are chemical drugs, especially chloroquine and antiviral drugs. Due to effective control, the proportion of clinical trials in China has been greatly reduced. Among the chemical drug clinical projects, chloroquine accounted for the largest proportion, followed by ritonavir、lopinavir and ridacive.
This report focuses on the investigation and analysis of chemical medication in COVID-19 and predicts the future market development of biopharmaceuticals under the influence of COVID-19.
Market Analysis and Insights: Global Chemical Medication in COVID-19 Market
The global Chemical Medication in COVID-19 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chemical Medication in COVID-19 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chemical Medication in COVID-19 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chemical Medication in COVID-19 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chemical Medication in COVID-19 market.
Global Chemical Medication in COVID-19 Scope and Market Size
Chemical Medication in COVID-19 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemical Medication in COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Remedsivir
Ardidol
Favipivir
Lopinavir/ritonavir (LPV/r)
Chloroquine
Others
Others such as: ribavirin, galidevir, darunavir, nitazoxanide, etc.
Segment by Application
COVID-19
Influenza
Malaria
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Gilead Sciences
AbbVie
Johnson & Johnson
Pfizer
Mylan
Bayer
Zhejiang Hisun
CSPC Pharmaceutical Group
Reyoung Pharmaceutical
Sihuan Pharmaceutical
Hikma Pharmaceuticals
Rising Pharmaceutical
Sun Pharma
Shanghai Pharma
Guangzhou Baiyunshan Guanghua Pharmaceutical
KPC Group
Jinghua Pharmaceutical Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemical Medication in COVID-19 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Remedsivir
1.2.3 Ardidol
1.2.4 Favipivir
1.2.5 Lopinavir/ritonavir (LPV/r)
1.2.6 Chloroquine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chemical Medication in COVID-19 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chemical Medication in COVID-19 Market Perspective (2016-2027)
2.2 Chemical Medication in COVID-19 Growth Trends by Regions
2.2.1 Chemical Medication in COVID-19 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chemical Medication in COVID-19 Historic Market Share by Regions (2016-2021)
2.2.3 Chemical Medication in COVID-19 Forecasted Market Size by Regions (2022-2027)
2.3 Chemical Medication in COVID-19 Industry Dynamic
2.3.1 Chemical Medication in COVID-19 Market Trends
2.3.2 Chemical Medication in COVID-19 Market Drivers
2.3.3 Chemical Medication in COVID-19 Market Challenges
2.3.4 Chemical Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical Medication in COVID-19 Players by Revenue
3.1.1 Global Top Chemical Medication in COVID-19 Players by Revenue (2016-2021)
3.1.2 Global Chemical Medication in COVID-19 Revenue Market Share by Players (2016-2021)
3.2 Global Chemical Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chemical Medication in COVID-19 Revenue
3.4 Global Chemical Medication in COVID-19 Market Concentration Ratio
3.4.1 Global Chemical Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical Medication in COVID-19 Revenue in 2020
3.5 Chemical Medication in COVID-19 Key Players Head office and Area Served
3.6 Key Players Chemical Medication in COVID-19 Product Solution and Service
3.7 Date of Enter into Chemical Medication in COVID-19 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical Medication in COVID-19 Breakdown Data by Type
4.1 Global Chemical Medication in COVID-19 Historic Market Size by Type (2016-2021)
4.2 Global Chemical Medication in COVID-19 Forecasted Market Size by Type (2022-2027)
5 Chemical Medication in COVID-19 Breakdown Data by Application
5.1 Global Chemical Medication in COVID-19 Historic Market Size by Application (2016-2021)
5.2 Global Chemical Medication in COVID-19 Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chemical Medication in COVID-19 Market Size (2016-2027)
6.2 North America Chemical Medication in COVID-19 Market Size by Type
6.2.1 North America Chemical Medication in COVID-19 Market Size by Type (2016-2021)
6.2.2 North America Chemical Medication in COVID-19 Market Size by Type (2022-2027)
6.2.3 North America Chemical Medication in COVID-19 Market Size by Type (2016-2027)
6.3 North America Chemical Medication in COVID-19 Market Size by Application
6.3.1 North America Chemical Medication in COVID-19 Market Size by Application (2016-2021)
6.3.2 North America Chemical Medication in COVID-19 Market Size by Application (2022-2027)
6.3.3 North America Chemical Medication in COVID-19 Market Size by Application (2016-2027)
6.4 North America Chemical Medication in COVID-19 Market Size by Country
6.4.1 North America Chemical Medication in COVID-19 Market Size by Country (2016-2021)
6.4.2 North America Chemical Medication in COVID-19 Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chemical Medication in COVID-19 Market Size (2016-2027)
7.2 Europe Chemical Medication in COVID-19 Market Size by Type
7.2.1 Europe Chemical Medication in COVID-19 Market Size by Type (2016-2021)
7.2.2 Europe Chemical Medication in COVID-19 Market Size by Type (2022-2027)
7.2.3 Europe Chemical Medication in COVID-19 Market Size by Type (2016-2027)
7.3 Europe Chemical Medication in COVID-19 Market Size by Application
7.3.1 Europe Chemical Medication in COVID-19 Market Size by Application (2016-2021)
7.3.2 Europe Chemical Medication in COVID-19 Market Size by Application (2022-2027)
7.3.3 Europe Chemical Medication in COVID-19 Market Size by Application (2016-2027)
7.4 Europe Chemical Medication in COVID-19 Market Size by Country
7.4.1 Europe Chemical Medication in COVID-19 Market Size by Country (2016-2021)
7.4.2 Europe Chemical Medication in COVID-19 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chemical Medication in COVID-19 Market Size (2016-2027)
8.2 Asia-Pacific Chemical Medication in COVID-19 Market Size by Type
8.2.1 Asia-Pacific Chemical Medication in COVID-19 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chemical Medication in COVID-19 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chemical Medication in COVID-19 Market Size by Type (2016-2027)
8.3 Asia-Pacific Chemical Medication in COVID-19 Market Size by Application
8.3.1 Asia-Pacific Chemical Medication in COVID-19 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chemical Medication in COVID-19 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chemical Medication in COVID-19 Market Size by Application (2016-2027)
8.4 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region
8.4.1 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chemical Medication in COVID-19 Market Size (2016-2027)
9.2 Latin America Chemical Medication in COVID-19 Market Size by Type
9.2.1 Latin America Chemical Medication in COVID-19 Market Size by Type (2016-2021)
9.2.2 Latin America Chemical Medication in COVID-19 Market Size by Type (2022-2027)
9.2.3 Latin America Chemical Medication in COVID-19 Market Size by Type (2016-2027)
9.3 Latin America Chemical Medication in COVID-19 Market Size by Application
9.3.1 Latin America Chemical Medication in COVID-19 Market Size by Application (2016-2021)
9.3.2 Latin America Chemical Medication in COVID-19 Market Size by Application (2022-2027)
9.3.3 Latin America Chemical Medication in COVID-19 Market Size by Application (2016-2027)
9.4 Latin America Chemical Medication in COVID-19 Market Size by Country
9.4.1 Latin America Chemical Medication in COVID-19 Market Size by Country (2016-2021)
9.4.2 Latin America Chemical Medication in COVID-19 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical Medication in COVID-19 Market Size (2016-2027)
10.2 Middle East & Africa Chemical Medication in COVID-19 Market Size by Type
10.2.1 Middle East & Africa Chemical Medication in COVID-19 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chemical Medication in COVID-19 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chemical Medication in COVID-19 Market Size by Type (2016-2027)
10.3 Middle East & Africa Chemical Medication in COVID-19 Market Size by Application
10.3.1 Middle East & Africa Chemical Medication in COVID-19 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chemical Medication in COVID-19 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chemical Medication in COVID-19 Market Size by Application (2016-2027)
10.4 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country
10.4.1 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Chemical Medication in COVID-19 Introduction
11.1.4 Gilead Sciences Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.1.5 Gilead Sciences Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Chemical Medication in COVID-19 Introduction
11.2.4 AbbVie Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Chemical Medication in COVID-19 Introduction
11.3.4 Johnson & Johnson Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Chemical Medication in COVID-19 Introduction
11.4.4 Pfizer Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Chemical Medication in COVID-19 Introduction
11.5.4 Mylan Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Chemical Medication in COVID-19 Introduction
11.6.4 Bayer Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Zhejiang Hisun
11.7.1 Zhejiang Hisun Company Details
11.7.2 Zhejiang Hisun Business Overview
11.7.3 Zhejiang Hisun Chemical Medication in COVID-19 Introduction
11.7.4 Zhejiang Hisun Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.7.5 Zhejiang Hisun Recent Development
11.8 CSPC Pharmaceutical Group
11.8.1 CSPC Pharmaceutical Group Company Details
11.8.2 CSPC Pharmaceutical Group Business Overview
11.8.3 CSPC Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.8.4 CSPC Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.8.5 CSPC Pharmaceutical Group Recent Development
11.9 Reyoung Pharmaceutical
11.9.1 Reyoung Pharmaceutical Company Details
11.9.2 Reyoung Pharmaceutical Business Overview
11.9.3 Reyoung Pharmaceutical Chemical Medication in COVID-19 Introduction
11.9.4 Reyoung Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.9.5 Reyoung Pharmaceutical Recent Development
11.10 Sihuan Pharmaceutical
11.10.1 Sihuan Pharmaceutical Company Details
11.10.2 Sihuan Pharmaceutical Business Overview
11.10.3 Sihuan Pharmaceutical Chemical Medication in COVID-19 Introduction
11.10.4 Sihuan Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.10.5 Sihuan Pharmaceutical Recent Development
11.11 Hikma Pharmaceuticals
11.11.1 Hikma Pharmaceuticals Company Details
11.11.2 Hikma Pharmaceuticals Business Overview
11.11.3 Hikma Pharmaceuticals Chemical Medication in COVID-19 Introduction
11.11.4 Hikma Pharmaceuticals Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.11.5 Hikma Pharmaceuticals Recent Development
11.12 Rising Pharmaceutical
11.12.1 Rising Pharmaceutical Company Details
11.12.2 Rising Pharmaceutical Business Overview
11.12.3 Rising Pharmaceutical Chemical Medication in COVID-19 Introduction
11.12.4 Rising Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.12.5 Rising Pharmaceutical Recent Development
11.13 Sun Pharma
11.13.1 Sun Pharma Company Details
11.13.2 Sun Pharma Business Overview
11.13.3 Sun Pharma Chemical Medication in COVID-19 Introduction
11.13.4 Sun Pharma Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.13.5 Sun Pharma Recent Development
11.14 Shanghai Pharma
11.14.1 Shanghai Pharma Company Details
11.14.2 Shanghai Pharma Business Overview
11.14.3 Shanghai Pharma Chemical Medication in COVID-19 Introduction
11.14.4 Shanghai Pharma Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.14.5 Shanghai Pharma Recent Development
11.15 Guangzhou Baiyunshan Guanghua Pharmaceutical
11.15.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
11.15.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
11.15.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Introduction
11.15.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.15.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
11.16 KPC Group
11.16.1 KPC Group Company Details
11.16.2 KPC Group Business Overview
11.16.3 KPC Group Chemical Medication in COVID-19 Introduction
11.16.4 KPC Group Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.16.5 KPC Group Recent Development
11.17 Jinghua Pharmaceutical Group
11.17.1 Jinghua Pharmaceutical Group Company Details
11.17.2 Jinghua Pharmaceutical Group Business Overview
11.17.3 Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.17.4 Jinghua Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.17.5 Jinghua Pharmaceutical Group Recent Development
11.18 Zhongsheng Pharma
11.18.1 Zhongsheng Pharma Company Details
11.18.2 Zhongsheng Pharma Business Overview
11.18.3 Zhongsheng Pharma Chemical Medication in COVID-19 Introduction
11.18.4 Zhongsheng Pharma Revenue in Chemical Medication in COVID-19 Business (2016-2021)
11.18.5 Zhongsheng Pharma Recent Development
11.18 North China Pharmaceutical Group
.1 North China Pharmaceutical Group Company Details
.2 North China Pharmaceutical Group Business Overview
.3 North China Pharmaceutical Group Chemical Medication in COVID-19 Introduction
.4 North China Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2016-2021)
.5 North China Pharmaceutical Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chemical Medication in COVID-19 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Remedsivir
Table 3. Key Players of Ardidol
Table 4. Key Players of Favipivir
Table 5. Key Players of Lopinavir/ritonavir (LPV/r)
Table 6. Key Players of Chloroquine
Table 7. Key Players of Others
Table 8. Global Chemical Medication in COVID-19 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Chemical Medication in COVID-19 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Chemical Medication in COVID-19 Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Chemical Medication in COVID-19 Market Share by Regions (2016-2021)
Table 12. Global Chemical Medication in COVID-19 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Chemical Medication in COVID-19 Market Share by Regions (2022-2027)
Table 14. Chemical Medication in COVID-19 Market Trends
Table 15. Chemical Medication in COVID-19 Market Drivers
Table 16. Chemical Medication in COVID-19 Market Challenges
Table 17. Chemical Medication in COVID-19 Market Restraints
Table 18. Global Chemical Medication in COVID-19 Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Chemical Medication in COVID-19 Market Share by Players (2016-2021)
Table 20. Global Top Chemical Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemical Medication in COVID-19 as of 2020)
Table 21. Ranking of Global Top Chemical Medication in COVID-19 Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Chemical Medication in COVID-19 Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chemical Medication in COVID-19 Product Solution and Service
Table 25. Date of Enter into Chemical Medication in COVID-19 Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chemical Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2016-2021)
Table 29. Global Chemical Medication in COVID-19 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Chemical Medication in COVID-19 Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Chemical Medication in COVID-19 Revenue Market Share by Application (2016-2021)
Table 33. Global Chemical Medication in COVID-19 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Chemical Medication in COVID-19 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Chemical Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Chemical Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Chemical Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Chemical Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Chemical Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Chemical Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Chemical Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Chemical Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Chemical Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Chemical Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Chemical Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Chemical Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chemical Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chemical Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chemical Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Chemical Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Chemical Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Chemical Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Chemical Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Chemical Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Chemical Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Chemical Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chemical Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chemical Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chemical Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Chemical Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 65. Gilead Sciences Company Details
Table 66. Gilead Sciences Business Overview
Table 67. Gilead Sciences Chemical Medication in COVID-19 Product
Table 68. Gilead Sciences Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 69. Gilead Sciences Recent Development
Table 70. AbbVie Company Details
Table 71. AbbVie Business Overview
Table 72. AbbVie Chemical Medication in COVID-19 Product
Table 73. AbbVie Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 74. AbbVie Recent Development
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Chemical Medication in COVID-19 Product
Table 78. Johnson & Johnson Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Chemical Medication in COVID-19 Product
Table 83. Pfizer Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Mylan Company Details
Table 86. Mylan Business Overview
Table 87. Mylan Chemical Medication in COVID-19 Product
Table 88. Mylan Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 89. Mylan Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Chemical Medication in COVID-19 Product
Table 93. Bayer Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 94. Bayer Recent Development
Table 95. Zhejiang Hisun Company Details
Table 96. Zhejiang Hisun Business Overview
Table 97. Zhejiang Hisun Chemical Medication in COVID-19 Product
Table 98. Zhejiang Hisun Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 99. Zhejiang Hisun Recent Development
Table 100. CSPC Pharmaceutical Group Company Details
Table 101. CSPC Pharmaceutical Group Business Overview
Table 102. CSPC Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 103. CSPC Pharmaceutical Group Recent Development
Table 104. Reyoung Pharmaceutical Company Details
Table 105. Reyoung Pharmaceutical Business Overview
Table 106. Reyoung Pharmaceutical Chemical Medication in COVID-19 Product
Table 107. Reyoung Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 108. Reyoung Pharmaceutical Recent Development
Table 109. Sihuan Pharmaceutical Company Details
Table 110. Sihuan Pharmaceutical Business Overview
Table 111. Sihuan Pharmaceutical Chemical Medication in COVID-19 Product
Table 112. Sihuan Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 113. Sihuan Pharmaceutical Recent Development
Table 114. Hikma Pharmaceuticals Company Details
Table 115. Hikma Pharmaceuticals Business Overview
Table 116. Hikma Pharmaceuticals Chemical Medication in COVID-19 Product
Table 117. Hikma Pharmaceuticals Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 118. Hikma Pharmaceuticals Recent Development
Table 119. Rising Pharmaceutical Company Details
Table 120. Rising Pharmaceutical Business Overview
Table 121. Rising Pharmaceutical Chemical Medication in COVID-19 Product
Table 122. Rising Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 123. Rising Pharmaceutical Recent Development
Table 124. Sun Pharma Company Details
Table 125. Sun Pharma Business Overview
Table 126. Sun Pharma Chemical Medication in COVID-19 Product
Table 127. Sun Pharma Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 128. Sun Pharma Recent Development
Table 129. Shanghai Pharma Company Details
Table 130. Shanghai Pharma Business Overview
Table 131. Shanghai Pharma Chemical Medication in COVID-19 Product
Table 132. Shanghai Pharma Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 133. Shanghai Pharma Recent Development
Table 134. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
Table 135. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
Table 136. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Product
Table 137. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 138. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
Table 139. KPC Group Company Details
Table 140. KPC Group Business Overview
Table 141. KPC Group Chemical Medication in COVID-19 Product
Table 142. KPC Group Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 143. KPC Group Recent Development
Table 144. Jinghua Pharmaceutical Group Company Details
Table 145. Jinghua Pharmaceutical Group Business Overview
Table 146. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Product
Table 147. Jinghua Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 148. Jinghua Pharmaceutical Group Recent Development
Table 149. Zhongsheng Pharma Company Details
Table 150. Zhongsheng Pharma Business Overview
Table 151. Zhongsheng Pharma Chemical Medication in COVID-19 Product
Table 152. Zhongsheng Pharma Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 153. Zhongsheng Pharma Recent Development
Table 154. North China Pharmaceutical Group Company Details
Table 155. North China Pharmaceutical Group Business Overview
Table 156. North China Pharmaceutical Group Chemical Medication in COVID-19 Product
Table 157. North China Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 158. North China Pharmaceutical Group Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemical Medication in COVID-19 Market Share by Type: 2020 VS 2027
Figure 2. Remedsivir Features
Figure 3. Ardidol Features
Figure 4. Favipivir Features
Figure 5. Lopinavir/ritonavir (LPV/r) Features
Figure 6. Chloroquine Features
Figure 7. Others Features
Figure 8. Global Chemical Medication in COVID-19 Market Share by Application: 2020 VS 2027
Figure 9. COVID-19 Case Studies
Figure 10. Influenza Case Studies
Figure 11. Malaria Case Studies
Figure 12. Others Case Studies
Figure 13. Chemical Medication in COVID-19 Report Years Considered
Figure 14. Global Chemical Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Chemical Medication in COVID-19 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Chemical Medication in COVID-19 Market Share by Regions: 2020 VS 2027
Figure 17. Global Chemical Medication in COVID-19 Market Share by Regions (2022-2027)
Figure 18. Global Chemical Medication in COVID-19 Market Share by Players in 2020
Figure 19. Global Top Chemical Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemical Medication in COVID-19 as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Chemical Medication in COVID-19 Revenue in 2020
Figure 21. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2016-2021)
Figure 22. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2022-2027)
Figure 23. North America Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Chemical Medication in COVID-19 Market Share by Type (2016-2027)
Figure 25. North America Chemical Medication in COVID-19 Market Share by Application (2016-2027)
Figure 26. North America Chemical Medication in COVID-19 Market Share by Country (2016-2027)
Figure 27. United States Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Chemical Medication in COVID-19 Market Share by Type (2016-2027)
Figure 31. Europe Chemical Medication in COVID-19 Market Share by Application (2016-2027)
Figure 32. Europe Chemical Medication in COVID-19 Market Share by Country (2016-2027)
Figure 33. Germany Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Chemical Medication in COVID-19 Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Chemical Medication in COVID-19 Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Chemical Medication in COVID-19 Market Share by Region (2016-2027)
Figure 43. China Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Chemical Medication in COVID-19 Market Share by Type (2016-2027)
Figure 51. Latin America Chemical Medication in COVID-19 Market Share by Application (2016-2027)
Figure 52. Latin America Chemical Medication in COVID-19 Market Share by Country (2016-2027)
Figure 53. Mexico Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Chemical Medication in COVID-19 Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Chemical Medication in COVID-19 Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Chemical Medication in COVID-19 Market Share by Country (2016-2027)
Figure 59. Turkey Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Chemical Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Gilead Sciences Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 68. Zhejiang Hisun Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 69. CSPC Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 70. Reyoung Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 71. Sihuan Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 72. Hikma Pharmaceuticals Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 73. Rising Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 74. Sun Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 75. Shanghai Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 76. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 77. KPC Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 78. Jinghua Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 79. Zhongsheng Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 80. North China Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…- 世界の新型コロナウイルス感染症用保険市場規模・現状・予測（2021年-2027年） In view of the enterprise to return to work and production and Covid-19.Some area in China, including Ningbo city, Hainan province, putian city, fujian province, by boosting set up Enterprise Prevention Covid-19 Insurance or Return to Work after Isolation and other innovation of insurance products.T…
- 世界の新型コロナウイルス感染症DNAワクチン市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 DNA Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 DNA Vaccine status, future forecast, growth opportunity, key market, and key play…
- 世界の新型コロナウイルス感染症ワクチン・治療薬市場規模・現状・予測（2021年-2027年） In 2020, the global COVID-19 Vaccines & Therapeutics market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2021-2026. This report focuses on the global COVID-19 Vaccines & Therapeutics status, future forecast, growth opportunity, …
- 世界の新型コロナウイルス感染症における回復用保険市場規模・現状・予測（2021年-2027年） In view of the enterprise to return to work and production and Covid-19.Some area in China, including Ningbo city, Hainan province, putian city, fujian province, by boosting set up Enterprise Prevention Covid-19 Insurance or Return to Work after Isolation and other innovation of insurance products.T…